JMP Securities Upgrades Anadys Pharmaceuticals (ANDS) to Market Outperform
Tweet
Share
E-mailGet Alerts ANDS Hot Sheet
Price: $3.70 --0%
Rating Summary:
0 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 9 | New: 13
Rating Summary:
0 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 9 | New: 13
Join SI Premium – FREE
JMP Securities upgraded Anadys Pharmaceuticals (NASDAQ: ANDS) from Market Perform to Market Outperform with a new price target of $3.00.
For more ratings news on Anadys Pharmaceuticals click here and for the rating history of Anadys Pharmaceuticals click here.
Shares of Anadys Pharmaceuticals closed at $0.82 yesterday.
For more ratings news on Anadys Pharmaceuticals click here and for the rating history of Anadys Pharmaceuticals click here.
Shares of Anadys Pharmaceuticals closed at $0.82 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BNP Paribas Exane Upgrades Polycab India Limited (POLYCAB:IN) to Outperform
- Piper Sandler Upgrades Alerus Financial Corp. (ALRS) to Overweight
- UBS Upgrades Treasury Wine Estates Ltd. (TWE:AU) (TSRYY) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
